Champions Oncology share price today

(CSBR)

Champions Oncology share price is $7.87 & ₹670.51 as on 25 Dec 2024, 2.30 'hrs' IST

$7.87

▲

-0.24

(-2.96%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Champions Oncology share price in Dollar and Rupees. Guide to invest in Champions Oncology from India. Also see the sentimental analysis on Indian investors investing in Champions Oncology. Get details on the Indian mutual funds that are investing in Champions Oncology. Get Analyst recommendations and forecasts along with all the Champions Oncology's financials.

Champions Oncology share price movements

Today's Low: $7.48
Today's High: $8.36
$7.87
4.96%
Downside
Day's Volatility :10.53%
Upside
5.86%
52 Weeks Low: $3.60
52 Weeks High: $8.88
$7.87
54.26%
Downside
52 Weeks Volatility :59.46%
Upside
11.37%

Champions Oncology Returns

Period	Champions Oncology Inc	Index (Russel 2000)
3 Months	63.62%	0.0%
6 Months	55.84%	0.0%
1 Year	48.63%	0.0%
3 Years	-0.38%	-21.1%

Champions Oncology Key Statistics

in dollars & INR

Previous Close	$8.11
Open	$8.03
Today's High	$8.36
Today's Low	$7.48
Market Capitalization	$107.8M
Today's Volume	$49.1K
52 Week High	$8.88
52 Week Low	$3.6001
Revenue TTM	$51.7M
EBITDA	$-1.2M
Earnings Per Share (EPS)	$-0.05
Profit Margin	-6.58%
Quarterly Earnings Growth YOY	-0.29%
Return On Equity TTM	-432.46%

How to invest in Champions Oncology from India?

It is very easy for Indian residents to invest directly in Champions Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Champions Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Champions Oncology or CSBR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Champions Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Champions Oncology shares which would translate to 0.108 fractional shares of Champions Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Champions Oncology, in just a few clicks!

Returns in Champions Oncology for Indian investors in Rupees

Investment Value

₹1,00,000

Champions Oncology investment value today

Current value as on today

₹1,50,729

Returns

₹50,729

(+50.73%)

Returns from Champions Oncology Stock

₹48,491 (+48.49%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Champions Oncology

183%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Champions Oncology on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 183% more investors are searching Champions Oncology in the last 30 days versus the previous period.

Global Institutional Holdings in Champions Oncology

Battery Management Corp
17.81%
NEA Management Company, LLC
12.61%
Tocqueville Asset Management L.P.
5.19%
Vanguard Group Inc
2.26%
Renaissance Technologies Corp
0.88%
BlackRock Inc
0.85%

Analyst Recommendation on Champions Oncology

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Champions Oncology(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Champions Oncology

What analysts predicted

Upside of 1.65%

Current:

$7.87

Target:

$8.00

Insights on Champions Oncology

Price Movement
In the last 1 month, CSBR stock has moved up by 81.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 14.06M → 13.48M (in $), with an average decrease of 4.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.31M → 728.0K (in $), with an average decrease of 44.6% per quarter
CSBR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 27.3%

Champions Oncology Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$27.1M	↑ 33.72%
Net Income	$128.0K	↓ 108.5%
Net Profit Margin	0.47%	↑ 7.91%

	FY20	Y/Y Change
Revenue	$32.1M	↑ 18.68%
Net Income	$-2.0M	↓ 1642.97%
Net Profit Margin	-6.15%	↓ 6.62%

	FY21	Y/Y Change
Revenue	$41.0M	↑ 27.76%
Net Income	$362.0K	↓ 118.33%
Net Profit Margin	0.88%	↑ 7.03%

	FY22	Y/Y Change
Revenue	$49.1M	↑ 19.66%
Net Income	$548.0K	↑ 51.38%
Net Profit Margin	1.12%	↑ 0.24%

	FY23	Y/Y Change
Revenue	$53.9M	↑ 9.69%
Net Income	$-5.3M	↓ 1073.54%
Net Profit Margin	-9.9%	↓ 11.02%

	FY24	Y/Y Change
Revenue	$50.2M	↓ 6.9%
Net Income	$-7.3M	↑ 36.38%
Net Profit Margin	-14.51%	↓ 4.61%

	Q3 FY23	Q/Q Change
Revenue	$12.6M	↓ 3.9%
Net Income	$-2.6M	↑ 0.2%
Net Profit Margin	-20.43%	↓ 0.84%

	Q4 FY23	Q/Q Change
Revenue	$11.6M	↓ 7.87%
Net Income	$-2.1M	↓ 19.29%
Net Profit Margin	-17.9%	↑ 2.53%

	Q1 FY24	Q/Q Change
Revenue	$12.0M	↑ 3.85%
Net Income	$-2.5M	↑ 22.16%
Net Profit Margin	-21.05%	↓ 3.15%

	Q2 FY24	Q/Q Change
Revenue	$14.0M	↑ 16.49%
Net Income	$-109.0K	↓ 95.69%
Net Profit Margin	-0.78%	↑ 20.27%

	Q3 FY24	Q/Q Change
Revenue	$14.1M	↑ 0.43%
Net Income	$1.3M	↓ 1304.59%
Net Profit Margin	9.34%	↑ 10.12%

	Q4 FY24	Q/Q Change
Revenue	$13.5M	↓ 4.07%
Net Income	$728.0K	↓ 44.55%
Net Profit Margin	5.4%	↓ 3.94%

	FY19	Y/Y Change
Profit	$12.8M	↑ 32.14%

	FY20	Y/Y Change
Profit	$15.2M	↑ 19.05%

	FY21	Y/Y Change
Profit	$19.6M	↑ 28.38%

	FY22	Y/Y Change
Profit	$25.5M	↑ 30.21%

	FY23	Y/Y Change
Profit	$24.3M	↓ 4.47%

	FY24	Y/Y Change
Profit	$20.8M	↓ 14.73%

	Q3 FY23	Q/Q Change
Profit	$4.9M	↓ 14.95%

	Q4 FY23	Q/Q Change
Profit	$5.0M	↑ 1.6%

	Q1 FY24	Q/Q Change
Profit	$4.2M	↓ 15.84%

	Q2 FY24	Q/Q Change
Profit	$6.8M	↑ 61.89%

	Q3 FY24	Q/Q Change
Profit	$7.0M	↑ 3.53%

	Q4 FY24	Q/Q Change
Profit	$6.4M	↓ 8.18%

	FY19	Y/Y Change
Operating Cash Flow	$1.9M	↓ 251.88%
Investing Cash Flow	$-834.0K	↓ 31.97%
Financing Cash Flow	$1.2M	↑ 9153.85%

	FY20	Y/Y Change
Operating Cash Flow	$2.9M	↑ 56.02%
Investing Cash Flow	$-2.2M	↑ 166.19%
Financing Cash Flow	$4.4M	↑ 267.41%

	FY21	Y/Y Change
Operating Cash Flow	$-1.7M	↓ 157.87%
Investing Cash Flow	$-3.2M	↑ 42.75%
Financing Cash Flow	$1.2M	↓ 72.96%

	FY22	Y/Y Change
Operating Cash Flow	$6.5M	↓ 486.5%
Investing Cash Flow	$-2.4M	↓ 24.77%
Financing Cash Flow	$207.0K	↓ 82.68%

	FY23	Y/Y Change
Operating Cash Flow	$4.0M	↓ 39.13%
Investing Cash Flow	$-2.9M	↑ 20.47%
Financing Cash Flow	$11.0K	↓ 94.69%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-4.0M	↑ 462.91%
Investing Cash Flow	$-668.0K	↓ 12.11%
Financing Cash Flow	$-590.0K	↑ 686.67%

Champions Oncology Technicals Summary

Sell

Neutral

Buy

Champions Oncology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Champions Oncology Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Champions Oncology Inc	81.76%	55.84%	48.63%	-0.38%	-2.72%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Champions Oncology Inc	NA	NA	0.0	-0.63	-4.32	-0.07	NA	-0.14
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Champions Oncology Inc	Sell	$107.8M	-2.72%	NA	-6.58%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Champions Oncology

champions oncology, inc. is engaged in the development of advanced technology solutions to personalize the development and use of oncology drugs. champions tumorgraft™ technology platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments, or tumorgrafts, in a manner that preserves the biological characteristics of the original human tumor. champions believes that these tumorgrafts, unlike cell line derived xenografts used in tradition testing, closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. the company offers personalized tumorgraft development, drug studies and genome sequencing as part of its personalized oncology solutions ("pos") whereby physicians can evaluate the effects of cancer drugs on their patients' tumorgrafts and understand the genetic make-up of their patient's tumor enabling them

Organization	Champions Oncology
Employees	210
CEO	Dr. Ronnie Morris M.D.
Industry	Health Technology

Management People of Champions Oncology

Name	Title
Dr. Ronnie Morris M.D.	CEO & Director
Mr. David Barry Miller M.B.A.	Chief Financial Officer
Dr. Maria Mancini Ph.D.	Chief Operating Officer
Mr. Arthur Hanson	Vice President of Technology
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS	Vice President of Global Marketing
Dr. Michael Ritchie M.B.A., Ph.D.	Chief Commercial Officer
Dr. Karin Abarca Heidemann Ph.D.	Executive Vice President of Global Scientific Operations
Dr. Marianna Zipeto Ph.D.	Executive Vice President of Commercial, Research Services & Partnering

Important FAQs about investing in Champions Oncology from India :

What is Champions Oncology share price today?

Champions Oncology share price today stands at $7.87, Open: $8.03 ; Previous Close: $8.11 ; High: $8.36 ; Low: $7.48 ; 52 Week High: $8.88 ; 52 Week Low: $3.60. The stock opens at $8.03, after a previous close of $8.11. The stock reached a daily high of $8.36 and a low of $7.48, with a 52-week high of $8.88 and a 52-week low of $3.60.

Can Indians buy Champions Oncology shares?

Yes, Indians can invest in the Champions Oncology (CSBR) from India.

With INDmoney, you can buy Champions Oncology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Champions Oncology at zero transaction cost.

How can I buy Champions Oncology shares from India?

It is very easy to buy Champions Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Champions Oncology be purchased?

Yes, you can buy fractional shares of Champions Oncology with INDmoney app.

What are the documents required to start investing in Champions Oncology stocks?

To start investing in Champions Oncology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.